This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (6) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Solapure, S. M. Articles by deSousa, S. M. Search for Related Content PubMed PubMed Citation Articles by Solapure, S. M. Articles by deSousa, S. M. Social Bookmarking                         What's this?

Development of a Microplate-Based Scintillation Proximity Assay for MraY Using a Modified Substrate

AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, India

P. Raphael

Quebec, Canada

C. N. Gayathri

AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, India

S. P. Barde

AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, India

B. Chandrakala

AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, India

K. S. Das

AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, India

S. M. deSousa

AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore, India

MraY is an established target for the discovery of antibacterial agents. The conventional assay for MraY uses radioactive substrate and analysis of products after paper chromatography or butanol extraction. Synthesis of radiolabeled substrate has been done in vitro using purified enzymes or by growing cells on radiolabeled precursors. The authors report a simple and rapid method to chemically radiolabel MraY substrate, UDP-MurNAc-pentapeptide. Specific activity obtained by this method was more than 100 times higher than the conventionally labeled substrate, and yields are high enough to support the requirements of high-throughput screening (HTS). The authors have developed a microplate-based homogeneous assay for MraY in which the product is captured on wheat germ agglutinin (WGA) scintillation proximity assay (SPA) beads. The assay was validated by showing inhibition by specific inhibitors of MraY but not by inhibitors of other enzymes of peptidoglycan synthesis. The assay uses wild-type membranes of Escherichia coli, giving it an advantage over recently described assays that need the protein to be overexpressed. In addition, it has an advantage over the high-throughput MraY-MurG coupled assay reported in the literature because it is MraY specific, and therefore hits obtained in this assay do not need further deconvolution. It has potential for use in HTS approaches to find novel inhibitors of MraY.

Key Words: scintillation proximity assay • antibacterial • MraY • modified substrate • HTS

Journal of Biomolecular Screening, Vol. 10, No. 2, 149-156 (2005)
DOI: 10.1177/1087057104272007


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. van Heijenoort Lipid Intermediates in the Biosynthesis of Bacterial Peptidoglycan Microbiol. Mol. Biol. Rev., December 1, 2007; 71(4): 620 - 635. [Abstract] [Full Text] [PDF]

				V. Ramachandran, B. Chandrakala, V. P. Kumar, V. Usha, S. M. Solapure, and S. M. de Sousa Screen for Inhibitors of the Coupled Transglycosylase-Transpeptidase of Peptidoglycan Biosynthesis in Escherichia coli. Antimicrob. Agents Chemother., April 1, 2006; 50(4): 1425 - 1432. [Abstract] [Full Text] [PDF]